A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit

Boun Kim Tan (1) , Emmanuel Vivier (1) , Karim Ait Bouziad (2) , Jean-Ralph Zahar (3) , Christian Pommier (1) , Laurence Parmeland (1) , Caroline Pariset (1) , Pauline Misslin (1) , Catherine Haond (4) , Philippe Poirié (1) , Laura Temime (2, 5) , Mounia N. Hocine (2, 5)

1 Centre hospitalier Saint Joseph - Saint Luc [Lyon]
2 MESuRS - Laboratoire Modélisation, épidémiologie et surveillance des risques sanitaires
3 Hôpital Avicenne [AP-HP]
4 Hôpital Edouard Herriot [CHU - HCL]
5 PACRI - Pasteur-Cnam Risques infectieux et émergents

Domains: Statistics [stat]; Statistics [stat]; Methodology [stat.ME]; Life Sciences [q-bio]; Santé publique et épidémiologie

Boun Kim Tan, Emmanuel Vivier, Karim Ait Bouziad, Jean-Ralph Zahar, Christian Pommier, et al.. A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit. Intensive Care Medicine, 2018, 44 (5), pp.672-673. ⟨10.1007/s00134-018-5079-y⟩. ⟨hal-02075873⟩